Article info

Original research
KALRN mutations promote antitumor immunity and immunotherapy response in cancer

Authors

  • Mengyuan Li Biomedical Informatics Research Lab,School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China Cancer Genomics Research Center, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China Big Data Research Institute, China Pharmaceutical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Yuxiang Ma Department of Basic Medicine, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China PubMed articlesGoogle scholar articles
  • You Zhong Department of Basic Medicine, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Qian Liu Biomedical Informatics Research Lab,School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China Cancer Genomics Research Center, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China Big Data Research Institute, China Pharmaceutical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Canping Chen Biomedical Informatics Research Lab,School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China Cancer Genomics Research Center, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China Big Data Research Institute, China Pharmaceutical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Lei Qiang Department of Basic Medicine, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Xiaosheng Wang Biomedical Informatics Research Lab,School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China Cancer Genomics Research Center, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China Big Data Research Institute, China Pharmaceutical University, Nanjing, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Xiaosheng Wang; xiaosheng.wang{at}cpu.edu.cn
View Full Text

Citation

Li M, Ma Y, Zhong Y, et al
KALRN mutations promote antitumor immunity and immunotherapy response in cancer

Publication history

  • Accepted September 10, 2020
  • First published October 9, 2020.
Online issue publication 
October 09, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.